Daplo 10 Tablet is primarily utilised to manage type 2 diabetes mellitus in adults. This medicine falls into a category of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.
In addition to its main use, this tablet also plays a significant role in reducing the risk of hospitalisation for heart failure in patients with established cardiovascular disease or multiple cardiovascular risk factors. It further helps in lowering the chance of sustained eGFR decline, end-stage kidney disease, cardiovascular death and hospitalisation for heart failure in patients with chronic kidney disease at risk of progression.
It's essential you consult your doctor for appropriate dosage and frequency. Inform your doctor about any pre-existing conditions or ongoing medications before starting this medication. If you experience any side effects while on this medication, immediately notify your doctor.